|
MOLECULES TO MEDICINES LTD
REGISTERED NUMBER: 12189862
STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
The principal activity of Molecules to Medicines Limited is biotechnology research.
The company is a private company limited by shares and is incorporated in England and Wales.
The registered office address is 33 St. Georges Road, London, England, N13 4AT.
Average number of employees
|
The average monthly number of employees, including directors, during the year was 1 (2022 - 1).
Director's confirmations
The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
|
|
MOLECULES TO MEDICINES LTD
REGISTERED NUMBER: 12189862
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 SEPTEMBER 2023
The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
................................................
N Miller
|
|
|
|
|
|
